Research graph
References from Safety and efficacy of ceralasertib, an ATR kinase inhibitor, combined with olaparib: dose escalation in advanced solid tumours and dose expansion in advanced breast cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41467-020-17127-2
10.1038/s41467-020-17127-2 · 2020 · External reference
10.1158/1078-0432.ccr-16-2273
10.1158/1078-0432.ccr-16-2273 · 2017 · External reference
10.1038/nrm2450
10.1038/nrm2450 · 2008 · External reference
10.1158/1078-0432.ccr-15-0479
10.1158/1078-0432.ccr-15-0479 · 2015 · External reference
10.1158/0008-5472.can-12-2753
10.1158/0008-5472.can-12-2753 · 2012 · External reference
10.1186/s12943-020-01227-0
10.1186/s12943-020-01227-0 · 2020 · External reference
10.1056/nejmoa0900212
10.1056/nejmoa0900212 · 2009 · External reference
10.1101/gad.334516.119
10.1101/gad.334516.119 · 2020 · External reference
10.1158/0008-5472.can-21-2997
10.1158/0008-5472.can-21-2997 · 2022 · External reference
10.1158/1078-0432.ccr-22-0568
10.1158/1078-0432.ccr-22-0568 · 2022 · External reference
10.1021/acs.jmedchem.8b01187
10.1021/acs.jmedchem.8b01187 · 2018 · External reference
10.1172/jci175369
10.1172/jci175369 · 2024 · External reference
10.1016/j.ygyno.2021.12.025
10.1016/j.ygyno.2021.12.025 · 2022 · External reference
10.1016/s1470-2045(21)00531-3
10.1016/s1470-2045(21)00531-3 · 2021 · External reference
10.1056/nejmoa2022485
10.1056/nejmoa2022485 · 2020 · External reference
10.1200/jco.19.02745
10.1200/jco.19.02745 · 2020 · External reference
10.1016/j.ejca.2021.03.029
10.1016/j.ejca.2021.03.029 · 2021 · External reference
10.1093/annonc/mdz012
10.1093/annonc/mdz012 · 2019 · External reference
10.1056/nejmoa2105215
10.1056/nejmoa2105215 · 2021 · External reference
10.1016/j.annonc.2022.09.159
10.1016/j.annonc.2022.09.159 · 2022 · External reference
10.1101/gad.290957.116
10.1101/gad.290957.116 · 2017 · External reference
10.1038/s41388-020-1328-y
10.1038/s41388-020-1328-y · 2020 · External reference
10.3390/diagnostics10020121
10.3390/diagnostics10020121 · 2020 · External reference
10.1038/s41416-025-03051-z
10.1038/s41416-025-03051-z · 2025 · External reference
10.1016/j.bbadis.2024.167574
10.1016/j.bbadis.2024.167574 · 2025 · External reference
10.1158/1538-7445.am2017-2494
10.1158/1538-7445.am2017-2494 · 2017 · External reference
10.1200/po.20.00439
10.1200/po.20.00439 · External reference
10.1016/j.ygyno.2021.08.024
10.1016/j.ygyno.2021.08.024 · 2021 · External reference
10.1158/1078-0432.ccr-22-2444
10.1158/1078-0432.ccr-22-2444 · 2023 · External reference
10.1158/1078-0432.ccr-23-1696
10.1158/1078-0432.ccr-23-1696 · 2023 · External reference
10.18632/oncotarget.6247
10.18632/oncotarget.6247 · 2015 · External reference
10.1158/1535-7163.mct-18-0010
10.1158/1535-7163.mct-18-0010 · 2018 · External reference
10.1158/1535-7163.mct-16-0239
10.1158/1535-7163.mct-16-0239 · 2017 · External reference
10.1136/jitc-2021-004306
10.1136/jitc-2021-004306 · 2022 · External reference
10.1136/jitc-2019-000340
10.1136/jitc-2019-000340 · 2020 · External reference
10.1038/s41467-024-45996-4
10.1038/s41467-024-45996-4 · 2024 · External reference
10.1038/s41591-024-02808-y
10.1038/s41591-024-02808-y · 2024 · External reference
10.1172/jci.insight.179599
10.1172/jci.insight.179599 · 2024 · External reference
Unresolved reference
External reference
10.1016/j.annonc.2022.03.180
10.1016/j.annonc.2022.03.180 · 2022 · External reference
10.1038/s41416-018-0286-4
10.1038/s41416-018-0286-4 · 2018 · External reference
10.1038/s41416-021-01560-1
10.1038/s41416-021-01560-1 · 2021 · External reference
10.1158/1078-0432.ccr-18-1891
10.1158/1078-0432.ccr-18-1891 · 2019 · External reference
10.1056/nejmoa1802905
10.1056/nejmoa1802905 · 2018 · External reference
10.1056/nejmoa1706450
10.1056/nejmoa1706450 · 2017 · External reference
10.1016/j.crphar.2021.100017
10.1016/j.crphar.2021.100017 · 2021 · External reference
10.1200/jco.19.02404
10.1200/jco.19.02404 · 2020 · External reference
10.1200/jco.2017.76.6915
10.1200/jco.2017.76.6915 · 2018 · External reference
10.1200/po.23.00635
10.1200/po.23.00635 · External reference
10.1038/s41416-023-02542-1
10.1038/s41416-023-02542-1 · 2024 · External reference
10.1158/2159-8290.cd-20-0868
10.1158/2159-8290.cd-20-0868 · 2021 · External reference
10.1038/s41591-023-02399-0
10.1038/s41591-023-02399-0 · 2023 · External reference
10.1158/2159-8290.cd-24-1500
10.1158/2159-8290.cd-24-1500 · 2025 · External reference
10.1093/jnci/djae098
10.1093/jnci/djae098 · 2024 · External reference
10.1158/1078-0432.ccr-16-1040
10.1158/1078-0432.ccr-16-1040 · 2017 · External reference
10.1038/s41416-020-01199-4
10.1038/s41416-020-01199-4 · 2021 · External reference
10.18632/oncotarget.12266
10.18632/oncotarget.12266 · 2016 · External reference
10.3390/cancers13040727
10.3390/cancers13040727 · 2021 · External reference
10.3390/cancers15164195
10.3390/cancers15164195 · 2023 · External reference
10.1038/s41573-022-00558-5
10.1038/s41573-022-00558-5 · 2023 · External reference
10.1038/s41416-026-03408-y
10.1038/s41416-026-03408-y · 2026 · External reference
